Limitations of antibiotic MIC-based PK-PD metrics: looking back to move forward

CB Landersdorfer, RL Nation - Frontiers in Pharmacology, 2021 - frontiersin.org
Within a few years after the first successful clinical use of penicillin, investigations were
conducted in animal infection models to explore a range of factors that were considered …

Recent advances of cell membrane-coated nanoparticles for therapy of bacterial infection

Y Song, X Zheng, J Hu, S Ma, K Li, J Chen… - Frontiers in …, 2023 - frontiersin.org
The rapid evolution of antibiotic resistance and the complicated bacterial infection
microenvironments are serious obstacles to traditional antibiotic therapy. Developing novel …

Research priorities towards precision antibiotic therapy to improve patient care

ZP Bulman, SG Wicha, EI Nielsen, JR Lenhard… - The Lancet …, 2022 - thelancet.com
Antibiotic resistance presents an incessant threat to our drug armamentarium that
necessitates novel approaches to therapy. Over the past several decades, investigation of …

Clinical pharmacological considerations in an early intravenous to oral antibiotic switch: are barriers real or simply perceived?

CB Landersdorfer, A Gwee, RL Nation - Clinical Microbiology and Infection, 2023 - Elsevier
Background Traditionally, there has been a common belief that ongoing iv antibiotic therapy
is superior to an early iv to oral switch, especially for severe infections. However, this may be …

When and how to use MIC in clinical practice?

S Magréault, F Jauréguy, E Carbonnelle, JR Zahar - Antibiotics, 2022 - mdpi.com
Bacterial resistance to antibiotics continues to be a global public health problem. The choice
of the most effective antibiotic and the use of an adapted dose in the initial phase of the …

Optimizing the use of beta-lactam antibiotics in clinical practice: a test of time

A Tilanus, G Drusano - Open Forum Infectious Diseases, 2023 - academic.oup.com
Despite their limitations, the pharmacokinetics (PK) and pharmacodynamics (PD) indices
form the basis for our current understanding regarding antibiotic development, selection …

Augmented Renal Clearance in Severe Infections—An Important Consideration in Vancomycin Dosing: A Narrative Review

Q Xiao, H Zhang, X Wu, J Qu, L Qin… - Frontiers in …, 2022 - frontiersin.org
Vancomycin is a hydrophilic antibiotic widely used in severe infections, including bacteremia
and central nervous system (CNS) infections caused by Gram-positive bacteria such as …

Natural killer cells in sepsis: Friends or foes?

F Wang, Y Cui, D He, L Gong, H Liang - Frontiers in Immunology, 2023 - frontiersin.org
Sepsis is one of the major causes of death in the hospital worldwide. The pathology of
sepsis is tightly associated with dysregulation of innate immune responses. The contribution …

Evaluation of empirical dosing regimens for meropenem in intensive care unit patients using population pharmacokinetic modeling and target attainment analysis

G An, CB Creech, N Wu, RL Nation, K Gu… - Antimicrobial agents …, 2023 - Am Soc Microbiol
In the present study, population pharmacokinetic (PK) analysis was performed based on
meropenem data from a prospective study conducted in 114 critically ill patients with a wide …

Aminoglycoside-mimicking carbonized polymer dots for bacteremia treatment

YR Chiou, CJ Lin, SG Harroun, YR Chen, L Chang… - Nanoscale, 2022 - pubs.rsc.org
Bacteremia and associated bacterial sepsis are potentially fatal and occur when the host
response to microbial invasion is impaired or compromised. This motivated us to develop …